-
Allenex AB (SSE:ALNX), Stockholm, Sweden ONCOlog Medical QA AB, Upplands Vasby, Sweden Business: Other Allenex said ONCOlog has filed for bankruptcy. Allenex, which owns 14.9% of ONCOlog, said its financial results will…
Published on 5/20/2013
-
AnaptysBio Inc., San Diego, Calif. U.S. Department of Defense, Washington, D.C. Business: Other, Antibodies AnaptysBio received a contract from the DoD's Defense Threat Reduction Agency (DTRA) to develop highly …
Published on 5/20/2013
-
Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Pharmaceuticals Astellas said it will close its OSI Pharmaceuticals LLC and Perseid Therapeutics LLC units and scale back its Astellas Research Institute of …
Published on 5/20/2013
-
Bioniche Life Sciences Inc. (TSX:BNC; ASX:BNC), Belleville, Ontario Business: Cancer Bioniche said it will not call a shareholder meeting despite the request of dissident shareholders. The company said its legal counsel…
Published on 5/20/2013
-
Clavis Pharma ASA (OSE:CLAVIS), Oslo, Norway Business: Cancer Clavis said it is undergoing a "significant down scaling" of its operations following the discontinued development of elacytarabine to treat acute …
Published on 5/20/2013
-
KV Pharmaceutical Co. (OTCQB:KVPHQ), St. Louis, Mo. Business: Genitourinary FDA filed a reply brief in the U.S. Court of Appeals for the District of Columbia Circuit to KV's appeal of a lower court's dismissal of a suit…
Published on 5/20/2013
-
Mercachem B.V., Nijmegen, the Netherlands ProQinase GmbH, Freiburg, Germany Business: Cancer CROs ProQinase and Mercachem received a 2.5 million ($3.3 million) grant from the EU's Eurostars program to develop a small …
Published on 5/20/2013
-
MethylGene Inc. (TSX:MYG), Montreal, Quebec Business: Cancer, Infectious MethylGene's board approved a proposal to reincorporate the company in the U.S., change its name to Mirati Therapeutics Inc. and list its shares …
Published on 5/20/2013
-
Neumedicines Inc., Pasadena, Calif. U.S. Department of Health and Human Services (HHS), Washington, D.C. Business: Other Neumedicines said HHS's Biomedical Advanced Research and Development Authority (BARDA) notified …
Published on 5/20/2013
-
Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Endocrine/Metabolic A German court dismissed a suit from Novartis seeking to block the assessment of the pharma's Type II diabetes drugs in the dipeptidyl …
Published on 5/20/2013
-
Ranbaxy Laboratories Ltd. (NSE:RANBAXY; BSE:500359), Gurgaon, India Business: Generics, Biosimilars Generics company Ranbaxy pleaded guilty to felony charges relating to the manufacture and distribution of generic drugs…
Published on 5/20/2013
-
Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer Roche's Pharma Research and Early Development (pRED) discovery oncology unit will provide awards of 1,000-4,000 ($1,297-$5188) for research on tumor-…
Published on 5/20/2013
-
Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Pharmaceuticals Sanofi said it will transform its research facility in Toulouse, France, into "autonomous structures" during the next five years under a …
Published on 5/20/2013
-
Santhera Pharmaceuticals Holding AG (SIX:SANN), Liestal, Switzerland Business: Ophthalmic, Musculoskeletal Santhera said the majority of shareholders at its annual shareholders' meeting supported the company's proposed …
Published on 5/20/2013
-
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI), Henderson, Nev. Business: Cancer Spectrum disclosed in an SEC filing that it received a subpoena in April from the SEC to produce documents related to the company's 2012 …
Published on 5/20/2013
-
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Genitourinary The U.S. Department of Justice filed a motion in the U.S. Court of Appeals for the Second Circuit for a stay, pending appeal, …
Published on 5/20/2013
-
Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Business: Endocrine/Metabolic Vivus named Martin Carroll, formerly head of global strategy and development at Boehringer Ingelheim (Ingelheim, Germany), and Jorge Plutzky,…
Published on 5/20/2013
-
Cancer Commons, Palo Alto, Calif. Imerman Angels, Chicago, Ill. Oregon Health & Science University, Portland, Ore. Science Exchange, Palo Alto, Calif. The Bonnie J. Addario Lung Cancer Foundation, San Carlos, Calif. The…
Published on 2/25/2013
-
Caprion Proteomics Inc., Montreal, Quebec Oncozyme Pharma Inc., Montreal, Quebec Pfizer Inc. (NYSE:PFE), New York, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Quebec Clinical Research Organization in Cancer (Q-…
Published on 2/25/2013
-
DiaGenic ASA (OSE:DIAG), Oslo, Norway Business: Diagnostic DiaGenic said in its 4Q12 report that it has terminated research activities and related employment positions outside of product development targeting Alzheimer'…
Published on 2/25/2013
-
Edelris s.a.s., Lyon, France Sygnature Discovery Ltd., Nottingham, U.K. Syncom B.V., Groningen, The Netherlands Taros Chemicals GmbH & Co. KG, Dortmund, Germany AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Bayer AG…
Published on 2/25/2013
-
Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Infectious Gilead and Teva settled a March 2010 patent suit claiming Teva's ANDA for…
Published on 2/25/2013
-
MassBiologics, Boston, Mass. Business: Infectious MassBiologics donated over one million doses of its Tetanus and Diphtheria combination vaccine to NGO Project Hope, which will distribute the vaccine to the Dominican …
Published on 2/25/2013
-
Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Pharmaceuticals Novartis said its board and Daniel Vasella, who departed last week as chairman, agreed to forgo a non-compete agreement and all related …
Published on 2/25/2013
-
Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of Pittsburgh, Pittsburgh, Pa. University of Texas Southwestern Medical Center, Dallas, Texas Business: Neurology, Genomics Roche, the university, and medical …
Published on 2/25/2013